Communiqués Morgan Stanley Deutsche Boerse AG

Actions

Marché Fermé - Deutsche Boerse AG Autres places de cotation 08:20:01 31/05/2024			Varia. 5j.	Varia. 1 janv.
89,71 ^EUR	+0,46%		-0,87%	+6,13%

31/05	Les entreprises de l'industrie du bâtiment et de l'aéronautique ont besoin de plus d'informations sur leurs activités et de plus d'informations sur leurs activités	MT
31/05	L'Arabie saoudite met à l'épreuve l'intérêt international avec la vente d'Aramco pour 13,1 milliards de dollars	RE

Equity Compensation Key Driver of Employee Retention and Engagement, Study Finds	30/05	BU
Morgan Stanley rates FPH as Equal-weight	30/05	AQ
Morgan Stanley rates TRS as Equal-weight	29/05	AQ
Ceres - Investors drive banks toward greater transparency on climate in 2024 proxy season	28/05	AQ
Morgan Stanley rates LLC as Equal-weight	28/05	AQ
Investors Drive Banks Toward Greater Transparency on Climate in 2024 Proxy Season	27/05	AQ
Morgan Stanley rates HMC as Equal-weight	27/05	AQ
Annual Study Shows Wide Majority of Employees Want Workplace Support for Financial Challenges	23/05	BU
Morgan Stanley rates TNE as Equal-weight	22/05	AQ
Aristocrat Leisure's $2.9bn Shareholder Windfall	22/05	AQ
Ted Pick to Speak at the Morgan Stanley Annual U.S. Financials, Payments & Commercial Real Estate Conference	21/05	BU
Morgan Stanley Wealth Management Announces Season Two Launches of Its Award-Winning Podcasts	21/05	BU
Morgan Stanley Sustainable Signals: New Survey Shows Value Creation Drives Corporate Sustainability Strategies Globally	21/05	BU
Arion Bank hf.: Tender offer results	21/05	AQ
Morgan Stanley rates MGR as Equal-weight	21/05	AQ
Mytheresa to Participate in Upcoming Investor Conferences	20/05	AQ
Morgan Stanley rates OML as Equal-weight	20/05	AQ
Morgan Stanley rates CSR as Equal-weight	20/05	AQ
Morgan Stanley rates NAB as Equal-weight	17/05	AQ
Morgan Stanley rates ANZ as Equal-weight	17/05	AQ

Aucun résultat pour cette recherche

L'absence de réduction de taux n'est pas un problème pour les actions, selon Andrew Slimmon de Morgan Stanley

Le 02 avril 2024 à 17:40

Edwards Lifesciences devrait bénéficier d'une " renaissance " dans le segment des TMTT, selon Morgan Stanley

Morgan Stanley : Nouvelle ère

Le 31 décembre 2023 à 06:04